PABA: benefits, dosage, contraindications

Mis à jour le

Para-aminobenzoic acid (PABA) is a naturally occurring non-protein amino acid. It is found in foods such as liver, eggs, kidneys, wheat germ, bran, milk and yogurt. It was previously thought to be a B vitamin, but it is now known to be neither a vitamin nor an essential nutrient for humans. It is interesting to note that pathogenic bacteria require PABA to synthesize folic acid. Sulfonamide antibiotics exert their antibacterial effect by inhibiting folic acid synthesis from PABA. PABA first appeared as a sunscreen agent after World War II because of its ability to absorb UVB rays. Orally, PABA is used for vitiligo, inflammatory myopathies, Peyronies disease (a disease causing erectile dysfunction), anemia, systemic lupus erythematosus, and headaches. It is also used for gray hair, hair loss, and skin aging.

Other name(s) 

Vitamin B10

Scientific name(s)

Para-aminobenzoic acid

Family or group: 

Amino acids


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


UV exposure
✪✪✪✪✪

PABA was once widely used as an active ingredient in sunscreens for its effectiveness in blocking UVB rays, thereby helping to prevent skin damage caused by sun exposure. PABA is an FDA-approved sunscreen.

Posologie

posologieTopical application


Peyronie's disease
✪✪✪✪✪

PABA is administered exogenously in cases of fibrotic diseases such as dermatomyositis, pemphigus, Peyronie's disease and scleroderma. Fibrosis may be caused by a long-term imbalance of serotonin and monoamine oxidase (MAO) activity at the tissue level. MAO requires substantial tissue oxygenation to function properly. PABA may enhance MAO activity by increasing tissue oxygenation. PABA is authorized by the FDA for the treatment of Peyronie's disease.

Posologie

posologieOral administration


Hair beauty
✪✪✪✪

PABA is reputed to darken gray hair, although specific studies are lacking to fully validate these effects.

Posologie

posologieOral administration


Properties


Dermatological effect

full-leaffull-leaffull-leafempty-leaf

Para-aminobenzoic acid was first discovered as a remedy for depigmentation of the coats of laboratory mice. Orally administered PABA can darken gray hair, although its precise mechanism on melanin metabolism remains unknown. When applied topically, PABA serves as a sunscreen filter, blocking UVB radiation and providing protection against UVA at high concentrations. This photoprotective action preserves epidermal cells.

Usages associés

UV exposure, Hair beauty


Safe dosage

Adult: 12 g

The oral dosage of PABA for inflammatory myopathies, pemphigus, and scleroderma is 12 g per day given in 4 to 6 doses. For Peyronie's disease, a dose of 12 g per day in four divided doses with meals has been used for 8 to 24 months. PABA sunscreens are available in concentrations of 1% to 15%.